Advertisement
Advertisement
Victoza

Victoza

liraglutide

Manufacturer:

Novo Nordisk A/S
Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.
Core Prescribing Info
Contents
Liraglutide
Indications/Uses
Adjunct to diet & exercise for adults, adolescents & childn ≥10 yr w/ insufficiently controlled type 2 DM as monotherapy when metformin is inappropriate; or in addition to other medicinal products for diabetes. Adjunct to diet, exercise & standard care therapy to reduce risk of major CV events in patients w/ type 2 DM & established CV disease who have inadequate glycaemic control.
Dosage/Direction for Use
SC Adult & childn ≥10 yr Initially 0.6 mg daily, increased to 1.2 mg after at least 1 wk. Max: 1.8 mg daily.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity.
MIMS Class
Antidiabetic Agents
ATC Classification
A10BJ02 - liraglutide ; Belongs to the class of glucagon-like peptide-1 (GLP-1) analogues. Used in the treatment of diabetes.
Presentation/Packing
Form
Victoza soln for inj 6 mg/mL
Packing/Price
1's
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement